TUCSON, Ariz. – The Arizona Center for Drug Discovery at the University of Arizona College of Pharmacy and the UArizona Cancer Center will host the second annual “Discovering New Medicines in Arizona” summit virtually via Zoom on Tuesday, Sept. 15.
"To Portal or not to Portal, that is the question; Efficacy of Patient Digital Engagement"
Joshua Lee, MD
We are streaming this online via Zoom, password 983069. To register your attendance, at the beginning of the presentation: please text 200926 to 866-327-3062. This code is only valid for the day of the event. If you haven't set up your account yet, please do so at cams.cme.arizona.edu, and be sure to enter your cell phone number so the system captures your attendance when you text the code.
We are streaming this online via Zoom. To register your attendance, at the beginning of the presentation: please text 189932 to 866-327-3062. This code is only valid for the day of the event. If you haven't set up your account yet, please do so at cams.cme.arizona.edu, and be sure to enter your cell phone number so the system captures your attendance when you text the code.
TUCSON, Ariz. – Understanding how cells respond to stress may provide new building blocks for designing future cancer and aging treatments, and a University of Arizona Health Sciences researcher has received a five-year, $1.6 million grant from the National Institute of General Medical Sciences to further study these implications.
TUCSON, AZ — The Arizona Poison and Drug Information Center at the University of Arizona Health Sciences in Tucson and Banner Health’s Banner Poison and Drug Information Center in Phoenix are warning residents statewide against using inappropriate medications and botanical products, like oleandrin, to prevent or treat COVID-19.
TUCSON, Ariz. – Findings from an investigative study at the Center for Innovation in Brain Science at the University of Arizona Health Sciences have shown that, for women with breast cancer, exposure to hormone-modulating therapies was associated with a significant decrease in the number of women who received a diagnosis of neurodegenerative disease – more specifically Alzheimer’s disease.
TUCSON, Ariz. – “Stem Cell Therapy and Platelet-Rich Plasma (PRP) for Osteoarthritis: Hope or Hype?” a free livestream lecture open to the public, is scheduled Wednesday, Sept. 2, 6-7:15 p.m. The 75-minute talk by C.
